Delighted to announce that Jellagen has been selected as a finalist in the Best Established Medtech category at the OBN Awards 2025!

Now in its 17th year, the OBN Awards celebrate innovation and excellence across the Life Sciences industry. This recognition is a testament to our ongoing dedication to advancing medical device technology and pioneering our collagen type 0 platform for tissue engineering.

A sincere thank you to OBN and to the independent judging panel for this recognition!

Congratulations in our group to Brainomix, Tachmed Healthcare, and all the outstanding finalists across every category!

We’re looking forward to connecting with colleagues, collaborators, and industry leaders on 26th November at the Royal Lancaster London.